资讯

FDA names Dr. Vinay Prasad as top vaccine official
In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
MedPage Today on MSN6 天
Vinay Prasad, Critic of COVID Measures, Picked as FDA's Top Vaccine Official
Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next ...
Vinay Prasad, a critic of drug industry and COVID-19 measures, to lead FDA vaccine program
Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...
The Cardiology Advisor1 天
Dr Vinay Prasad to Head FDA Vaccine, Biologics Division
The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.
US FDA names agency critic Vinay Prasad as top vaccine official
The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...
The American Bazaar6 天
FDA names Vinay Prasad as its new vaccine chief
The Food and Drug Administration (FDA) has named Indian American hematologist-oncologist Dr. Vinay Prasad, an outspoken ...
Cancer Therapy Advisor5 天
Dr Vinay Prasad Named New Head of CBER
We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited content, log in or register for free.
FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...
CNN6 天
FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division
Vinay Prasad, a hematologist oncologist ... of the government’s response and its vaccine policies during the Covid-19 pandemic. He replaces Dr. Peter Marks, who helped lead the division for ...
The Hill6 天
FDA taps critic of COVID policies, drug industry to lead vaccines division
The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of more stringent approval standards, to lead the agency’s ...